Cargando…
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal‐derived extracellular vesicles
INTRODUCTION: Intellectual disability, accelerated aging, and early‐onset Alzheimer‐like neurodegeneration are key brain pathological features of Down syndrome (DS). Although growing research aims at the identification of molecular pathways underlying the aging trajectory of DS population, data on i...
Autores principales: | Perluigi, Marzia, Picca, Anna, Montanari, Elita, Calvani, Riccardo, Marini, Federico, Matassa, Roberto, Tramutola, Antonella, Villani, Alberto, Familiari, Giuseppe, Domenico, Fabio Di, Butterfield, D. Allan, Oh, Kenneth J., Marzetti, Emanuele, Valentini, Diletta, Barone, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131479/ https://www.ncbi.nlm.nih.gov/pubmed/34812584 http://dx.doi.org/10.1002/alz.12499 |
Ejemplares similares
-
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
por: Di Domenico, Fabio, et al.
Publicado: (2019) -
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
por: Perluigi, Marzia, et al.
Publicado: (2020) -
It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease
por: Tramutola, Antonella, et al.
Publicado: (2016) -
Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia
por: Sirago, Giuseppe, et al.
Publicado: (2022) -
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018)